Cannabis License Decline: Why Legal Marijuana Businesses Are Closing

Executive Summary

The United States cannabis industry has experienced seven consecutive quarters of active business license decline, with the total number of licensed operators falling 9% over a two-year period ending in Q2 2026. This sustained contraction represents the first prolonged downturn in state-legal cannabis licensing since Colorado and Washington launched adult-use programs in 2014. The decline affects cultivation, manufacturing, retail, and testing licenses across multiple jurisdictions, driven by a convergence of factors including oversupply, compressed wholesale prices, high tax burdens, regulatory compliance costs, and restricted access to traditional banking and bankruptcy protections. The contraction has forced thousands of small operators out of business while accelerating consolidation among multi-state operators (MSOs) with access to capital. This trend carries profound implications for market structure, consumer access, social equity programs, state tax revenues, and the viability of the regulated cannabis model as federal rescheduling discussions continue.

Why This Matters

The license decline affects every stakeholder in the $30 billion U.S. cannabis economy, from 500,000 direct employees to state treasuries collecting $4.2 billion annually in cannabis taxes. For patients, fewer licensed operators means reduced access points, particularly in rural areas where marginal dispensaries have closed. Medical cannabis patients in states like Oklahoma and Oregon have watched their nearest licensed dispensary move 20-30 miles farther away as rural retailers surrender licenses. Approximately 6.4 million registered medical cannabis patients nationwide depend on the licensed supply chain for consistent access to tested products. State governments face immediate fiscal pressure. California projected $1.1 billion in cannabis tax revenue for fiscal year 2025-2026 but collected only $873 million through April 2026, a 21% shortfall attributed partly to license attrition. Colorado, Washington, Oregon, Michigan, and Illinois have all revised revenue projections downward for 2026-2027 as the tax base contracts. Small business owners represent the most directly affected group. An estimated 3,200 cannabis businesses have closed or surrendered licenses since Q1 2024, according to data compiled by Whitney Economics and Marijuana Business Daily. These closures have eliminated approximately 38,000 jobs, disproportionately affecting social equity licensees who entered the market with limited capital reserves and faced the steepest barriers to accessing debt financing. Multi-state operators view the contraction as a market correction creating acquisition opportunities. Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano have collectively announced $890 million in acquisitions of distressed assets since January 2025, purchasing cultivation facilities, retail locations, and brand portfolios at 30-50% discounts to 2022 valuations. Investors tracking the sector have watched the MSOS ETF decline 34% from its May 2024 peak, reflecting concerns about oversupply, margin compression, and the slower-than-expected pace of federal reform. The license decline signals a maturation phase that some analysts compare to the craft brewery consolidation of 2016-2019, when thousands of small breweries closed or were acquired after rapid expansion created unsustainable competition.

Background and History: From Expansion to Contraction

The current license decline follows an unprecedented 12-year expansion that saw the number of state-legal cannabis licenses grow from fewer than 1,000 in 2012 to a peak of approximately 47,300 in Q4 2023.

The Early Expansion Era (2012-2016)

Colorado and Washington became the first states to license adult-use cannabis businesses following voter approval of Amendment 64 and Initiative 502 in November 2012. Colorado issued its first adult-use retail licenses in January 2014, beginning with 136 stores. Washington followed in July 2014 with an initial 24 licensed retailers. Both states employed competitive application processes with caps on total licenses, creating scarcity value that supported early profitability. By December 2016, Colorado had issued approximately 1,450 active licenses across all categories, while Washington maintained roughly 1,100. Oregon, which launched adult-use sales in October 2015, took a different approach by removing license caps and allowing unlimited applications for qualified operators. Oregon issued 1,850 licenses in its first year alone, foreshadowing the oversupply challenges that would emerge by 2019. Medical cannabis programs in 23 states during this period operated under much tighter license restrictions, with many states limiting the total number of dispensaries to between 5 and 50 statewide. This scarcity model kept medical license values high—a Florida medical dispensary license traded for $49 million in 2016.

The Gold Rush Period (2017-2019)

California's launch of adult-use licensing in January 2018 marked the beginning of explosive license growth. As the world's fifth-largest economy and home to a decades-old cannabis culture, California issued 6,200 provisional licenses in its first six months. By December 2019, the state had issued more than 11,000 licenses, though only about 8,400 remained active due to operators failing to convert provisional licenses to annual status. Massachusetts, Michigan, Nevada, Maine, and Illinois launched adult-use programs between 2018 and 2020, each adding thousands of licenses. Michigan adopted an open-license model similar to Oregon's, issuing more than 1,600 licenses in its first 18 months. The national license count grew from approximately 8,500 in January 2017 to more than 32,000 by December 2019, a 276% increase in three years. This period saw the rise of multi-state operators pursuing aggressive expansion strategies funded by Canadian capital markets. Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs collectively raised more than $3 billion between 2017 and 2019, using the capital to acquire licenses in limited-license states and build cultivation capacity ahead of anticipated federal legalization. Wholesale cannabis prices remained relatively stable during this period despite supply growth, as new adult-use markets absorbed production. Oregon represented the exception, where unlimited licensing created severe oversupply by 2018. Oregon wholesale flower prices fell from $1,800 per pound in 2016 to $650 per pound by December 2018, forcing hundreds of small cultivators to operate at a loss.

Pandemic Disruption and Peak Licensing (2020-2023)

The COVID-19 pandemic paradoxically accelerated cannabis license growth. Most states designated cannabis businesses as essential services, allowing continued operation during lockdowns. Consumer demand surged as people spent more time at home, with U.S. cannabis sales growing 46% in 2020 to reach $17.5 billion. Strong sales and profitability attracted new applicants, and states facing budget shortfalls welcomed license fee revenue. The national license count grew from 32,000 in January 2020 to a peak of 47,300 in Q4 2023, with particularly rapid growth in Oklahoma, California, Michigan, Oregon, and Colorado. Oklahoma's medical program, which imposed no license caps and minimal barriers to entry, issued more than 9,000 licenses by mid-2022, creating the highest per-capita dispensary density in the nation. However, wholesale prices began declining sharply in 2021 as cultivation capacity outpaced demand growth. California wholesale flower prices fell from $1,200 per pound in Q1 2020 to $500 per pound by Q4 2022. Michigan, Colorado, and Oregon experienced similar declines. By 2023, wholesale cannabis prices in mature markets had fallen 60-75% from their 2019-2020 peaks, compressing margins throughout the supply chain.

The Contraction Begins (Q1 2024-Present)

The first quarter of 2024 marked the inflection point. For the first time since state-legal markets launched, the total number of active cannabis licenses declined quarter-over-quarter. Approximately 1,200 licenses were surrendered, revoked, or allowed to lapse in Q1 2024, concentrated in cultivation and retail categories. The decline continued through each subsequent quarter, with Q2 2026 data showing the seventh consecutive quarter of contraction. Oklahoma experienced the most dramatic decline, with active licenses falling from a peak of 9,100 in Q2 2022 to approximately 5,800 by Q1 2026, a 36% reduction. California's active license count fell from 11,400 in Q4 2023 to 9,900 by Q1 2026. Oregon, Colorado, and Michigan each saw declines of 12-18% over the same period. The contraction has been most severe among small cultivators and rural retailers operating on thin margins. Cultivation licenses have declined 14% nationally since Q4 2023, while retail licenses have fallen 7%. Manufacturing and testing licenses have remained relatively stable, declining only 3-4%, as these segments serve essential supply chain functions with less direct exposure to wholesale price compression.

Key Players and Stakeholders

State Regulatory Agencies

State cannabis control boards and departments of revenue administer licensing programs and have responded to the contraction with varying approaches. The California Department of Cannabis Control has reduced certain license fees by 20% and extended renewal deadlines to help struggling operators. The Oklahoma Medical Marijuana Authority has maintained its open-license policy but increased enforcement against non-compliant operators, contributing to license attrition. Colorado's Marijuana Enforcement Division has proposed allowing licensed operators to enter bankruptcy proceedings under state law, though federal bankruptcy protections remain unavailable due to cannabis's Schedule I status under the Controlled Substances Act.

Multi-State Operators

The largest MSOs have used the contraction to consolidate market share. Curaleaf Holdings operates 151 dispensaries across 18 states and has acquired 14 distressed competitors since January 2025. Trulieve Cannabis Corp., dominant in Florida with 196 locations, has expanded into struggling markets by purchasing cultivation facilities in California and Pennsylvania at steep discounts. Green Thumb Industries, Cresco Labs, and Verano Holdings have pursued similar strategies, collectively spending $890 million on acquisitions of distressed assets in 2025-2026.

Small and Independent Operators

Small cultivators, manufacturers, and retailers have borne the brunt of the contraction. The California Cannabis Industry Association estimates that 40% of the state's small cultivators have closed or stopped renewing licenses since 2023. Many operators cite the inability to compete with vertically integrated MSOs that control cultivation, manufacturing, and retail, allowing them to maintain profitability through margin capture across the supply chain.

Social Equity Licensees

Social equity programs designed to promote participation by communities disproportionately harmed by cannabis prohibition have been particularly affected. Illinois, Massachusetts, Michigan, and California have all reported higher closure rates among social equity licensees compared to the broader license population. In Illinois, 31% of social equity dispensary licensees have closed or sold their licenses since receiving approval, according to state data through March 2026. Limited access to capital, delayed license processing, and competition from well-funded MSOs have undermined equity program goals.

Industry Associations and Advocacy Groups

The National Cannabis Industry Association, U.S. Cannabis Council, and state-level trade groups have lobbied for regulatory relief, including reduced license fees, tax reform, and federal banking access. The Minority Cannabis Business Association has called for emergency funding and technical assistance for social equity licensees facing closure. These groups have also advocated for federal rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, which would allow licensed businesses to deduct ordinary business expenses under 26 U.S.C. § 280E and potentially access traditional bankruptcy protections.

Legal and Regulatory Framework

Cannabis remains a Schedule I controlled substance under the Controlled Substances Act, 21 U.S.C. § 812, creating a fundamental tension between state licensing regimes and federal law. State cannabis licensing operates under the authority of individual state statutes and constitutional amendments. California's Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) establishes the legal framework for licensing in that state. Colorado operates under Article XVIII, Section 16 of the state constitution and the Colorado Marijuana Code, C.R.S. § 44-10-101 et seq. Each state maintains distinct licensing categories, application requirements, fee structures, and operational regulations. The federal prohibition creates cascading legal barriers that have contributed to license decline. Under 26 U.S.C. § 280E, cannabis businesses cannot deduct ordinary business expenses from gross income for federal tax purposes, resulting in effective tax rates of 40-70% of gross profit. This tax burden has made marginal operators unprofitable even when generating positive cash flow. Cannabis businesses also cannot access FDIC-insured banking services without exposing financial institutions to potential prosecution for money laundering under 18 U.S.C. § 1956. While the Financial Crimes Enforcement Network (FinCEN) issued guidance in 2014 establishing a framework for banks serving cannabis businesses, fewer than 800 of the nation's 4,800 banks and credit unions actively serve the industry as of 2026. This forces most operators to conduct business in cash, increasing security costs and operational complexity. The inability to access federal bankruptcy protections under 11 U.S.C. § 101 et seq. has prevented struggling cannabis businesses from reorganizing debt or achieving orderly liquidation. Federal bankruptcy courts have consistently dismissed cannabis business cases, most recently in Hacienda Company, LLC v. Lemon Glow Company (9th Cir. 2024), holding that a debtor cannot reorganize under Chapter 11 while continuing to violate the Controlled Substances Act. This has forced cannabis operators into state-law receiverships or informal wind-downs, often resulting in complete losses for creditors and equity holders. The Department of Justice under the Biden administration maintained the Cole Memorandum policy of deprioritizing enforcement against state-legal cannabis businesses complying with robust regulatory frameworks. However, the lack of permanent statutory protection has created ongoing legal uncertainty that constrains access to capital and increases the cost of compliance. In May 2024, the Drug Enforcement Administration published a notice of proposed rulemaking to reschedule cannabis from Schedule I to Schedule III under 21 U.S.C. § 811. If finalized, Schedule III classification would allow cannabis businesses to deduct ordinary business expenses under 26 U.S.C. § 280E, potentially improving profitability by 15-30% for marginal operators. However, rescheduling would not resolve banking access or bankruptcy issues, as cannabis would remain a controlled substance under federal law. The rulemaking process has extended through multiple comment periods and is not expected to conclude before Q4 2026 at the earliest.

State-by-State Breakdown

License decline has affected states differently based on market maturity, license structure, tax policy, and regulatory approach.

California

California's active license count declined from 11,400 in Q4 2023 to 9,900 in Q1 2026, a 13% reduction. The state's high tax burden—including a 15% excise tax, local taxes often exceeding 10%, and cultivation taxes of $10.08 per ounce for flower—has driven consumers to the illicit market, which accounts for an estimated 60% of total cannabis sales. The Department of Cannabis Control eliminated cultivation taxes in July 2025 and reduced certain license fees by 20%, but closures have continued. Small cultivators in Humboldt, Mendocino, and Trinity counties have been particularly affected, with more than 800 cultivation licenses surrendered in the traditional growing regions since 2023.

Oklahoma

Oklahoma experienced the steepest decline, from 9,100 active licenses in Q2 2022 to 5,800 in Q1 2026, a 36% reduction. The state's open-license medical program created extreme oversupply, with one dispensary for every 1,800 residents at the peak. Wholesale flower prices fell to $300-400 per pound by 2025, below the cost of production for most operators. The Oklahoma Medical Marijuana Authority has increased enforcement against non-compliant operators and implemented stricter financial disclosure requirements, contributing to attrition. Despite the decline, Oklahoma still maintains the highest per-capita dispensary density in the nation.

Oregon

Oregon's license count fell from approximately 3,800 in Q4 2023 to 3,200 in Q1 2026, a 16% decline. The state's unlimited licensing model created chronic oversupply, with wholesale prices remaining below $500 per pound since 2019. The Oregon Liquor and Cannabis Commission has not implemented significant regulatory changes, allowing market forces to drive consolidation. Rural dispensaries have closed at higher rates than urban locations, with 47 of Oregon's 36 counties losing at least one dispensary since 2024.

Colorado

Colorado's active license count declined from approximately 3,400 in Q4 2023 to 2,900 in Q1 2026, a 15% reduction. As the nation's first adult-use market, Colorado has experienced natural market maturation. The state's Marijuana Enforcement Division has proposed regulatory reforms including allowing state-law bankruptcy proceedings and reducing license fees. Denver, Colorado Springs, and Aurora have maintained relatively stable dispensary counts, while mountain resort communities and rural areas have seen closures.

Michigan

Michigan's license count fell from approximately 2,900 in Q4 2023 to 2,500 in Q1 2026, a 14% decline. The state's open-license model and low barriers to entry created rapid expansion followed by oversupply. Wholesale flower prices declined from $2,000 per pound in 2020 to $600 per pound by 2025. The Cannabis Regulatory Agency has maintained consistent enforcement but has not implemented major policy changes. Detroit and surrounding Wayne County have seen the most significant closures, with 68 dispensaries closing since January 2024.

Illinois

Illinois has experienced more modest decline, with active licenses falling approximately 6% from Q4 2023 to Q1 2026. The state's limited-license structure and high barriers to entry have created more stable market conditions, but high taxes—including a 7% wholesale tax and retail taxes ranging from 10-25% based on THC content—have constrained growth. Social equity licensees have struggled disproportionately, with closure rates nearly double those of established operators.

Massachusetts

Massachusetts has seen a 7% license decline since Q4 2023, concentrated among small cultivators and rural retailers. The state's Cannabis Control Commission has implemented a tiered licensing structure allowing smaller operators to enter with reduced fees and requirements, but access to capital remains the primary barrier. The commission has also prioritized social equity applicants, though many have struggled to achieve profitability in a competitive market dominated by MSOs.

Other States

Arizona, Nevada, New Jersey, New Mexico, and Montana have experienced license declines of 4-8% since Q4 2023. Newer markets including Connecticut, Rhode Island, Maryland, Missouri, and Ohio have continued to add licenses as programs mature, though growth rates have slowed significantly compared to initial launch periods. Florida's medical program has remained relatively stable with approximately 600 active licenses, constrained by the state's vertical integration requirement and limited number of licensed operators.

Market and Business Implications

The license decline represents a fundamental market correction with profound implications for industry structure, pricing, employment, and investment. Wholesale cannabis prices have stabilized in most markets after years of decline, suggesting supply and demand are reaching equilibrium. California wholesale flower prices have held steady at $450-550 per pound through Q1 2026 after falling continuously from 2020 through 2024. Michigan and Colorado have seen similar stabilization. Industry analysts project wholesale prices will remain flat or increase modestly through 2027 as supply contracts to match demand. Retail prices have declined more gradually than wholesale prices, as dispensaries maintain margins to cover high operating costs. The national average retail price for one ounce of cannabis flower fell from $326 in Q1 2023 to $287 in Q1 2026, according to data from Cannabis Benchmarks. However, retail prices remain 2-3 times higher than illicit market prices in high-tax states, constraining legal market growth. Consolidation has accelerated dramatically. The top 10 MSOs now control approximately 38% of total U.S. cannabis sales, up from 29% in 2023. Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano collectively operate more than 700 dispensaries and have acquired more than 100 competitors since 2024. This consolidation has improved operational efficiency and profitability for the largest operators while reducing competition and consumer choice in some markets. Employment in the licensed cannabis industry has declined from a peak of approximately 520,000 in Q4 2023 to 482,000 in Q1 2026, according to Leafly's annual jobs report. Cultivation and trimming positions have been most affected, declining 18% as automated processing systems replace manual labor and outdoor cultivation operations close. Retail employment has declined more modestly, falling 6%, as surviving dispensaries maintain staffing levels. State tax revenues have declined in mature markets but continue growing in newer programs. California collected $873 million in cannabis tax revenue through April 2026, down from $1.04 billion in fiscal year 2023-2024. Colorado's cannabis tax revenue declined 8% year-over-year in 2025. However, total U.S. cannabis tax revenue continues to grow as newer markets mature, reaching an estimated $4.2 billion in 2025. Capital markets have responded negatively to the contraction. The AdvisorShares Pure US Cannabis ETF (MSOS) declined 34% from May 2024 to May 2026, underperforming the S&P 500 by 47 percentage points. Debt financing has become more expensive, with interest rates for cannabis operators ranging from 12-18% compared to 8-12% in 2022. Equity valuations have compressed, with publicly traded MSOs trading at an average of 1.2x revenue compared to 3.5x in 2021. The contraction has created acquisition opportunities for well-capitalized operators and private equity firms. Private equity investment in cannabis reached $1.8 billion in 2025, with most capital directed toward acquiring distressed assets and consolidating fragmented markets. Firms including Poseidon Asset Management, Tuatara Capital, and Silver Spike Capital have raised dedicated cannabis funds to pursue consolidation strategies. Ancillary businesses serving the cannabis industry have also been affected. Equipment manufacturers, packaging suppliers, testing laboratories, and compliance software providers have all experienced reduced demand as the customer base contracts. However, some segments have benefited from consolidation, as larger operators standardize on preferred vendors and increase order volumes.

What Experts Say

Industry analysts, economists, and policy experts view the license decline as a necessary market correction that will ultimately strengthen the industry's long-term viability. Beau Whitney, senior economist at Whitney Economics, described the contraction as inevitable given the oversupply conditions that developed in multiple states. According to Whitney's analysis, the national cannabis market was oversupplied by approximately 30% at the peak in 2023, with production capacity exceeding consumption by more than 2 million pounds annually. Whitney projects the contraction will continue through 2027 before stabilizing, with total active licenses declining to approximately 38,000-40,000 nationally. Aaron Smith, co-founder and chief executive officer of the National Cannabis Industry Association, has emphasized the need for federal banking access and tax reform to prevent further closures of small operators. According to Smith, the inability to access traditional banking and the burden of 26 U.S.C. § 280E taxation create insurmountable barriers for undercapitalized businesses operating on thin margins. Smith has called on Congress to pass the SAFER Banking Act and reform Section 280E regardless of the timeline for comprehensive federal legalization. Kris Krane, president of 4Front Ventures, a multi-state operator, has described the current environment as a transition from a growth phase to a mature industry phase. According to Krane, the operators surviving the contraction will be those with strong balance sheets, operational efficiency, and vertical integration allowing margin capture across the supply chain. Krane projects that the top 20 MSOs will eventually control 60-70% of the U.S. cannabis market, similar to concentration levels in the alcohol industry. Amanda Reiman, vice president of public policy research at New Frontier Data, has expressed concern about the impact on social equity programs and small business participation. According to Reiman's research, social equity licensees face closure rates 40-60% higher than the overall license population due to limited access to capital, delayed licensing processes, and competition from well-funded MSOs. Reiman has called for emergency grant programs and technical assistance to prevent the complete elimination of social equity participation in the legal market. Troy Dayton, chief executive officer of The Arcview Group, a cannabis investment network, has characterized the current period as a buyer's market creating opportunities for strategic consolidation. According to Dayton, asset valuations have declined to levels that make acquisitions attractive for operators with access to capital. Dayton projects that private equity investment will accelerate through 2027 as firms acquire distressed assets at discounts of 40-60% to peak valuations. Dale Gieringer, director of California NORML, has attributed California's particularly severe license decline to the state's high tax burden and failure to eliminate the illicit market. According to Gieringer, California's 15% excise tax combined with local taxes often exceeding 10% creates retail prices 2-3 times higher than illicit market prices, driving consumers away from licensed operators. Gieringer has advocated for eliminating the excise tax entirely and replacing it with a modest ad valorem tax on wholesale transactions.

What's Next

The license decline is projected to continue through at least Q4 2026 and potentially into 2027 before stabilizing, with several key decision points and scenarios ahead. The most significant near-term catalyst is the DEA's final decision on cannabis rescheduling. The agency's proposed rule to move cannabis from Schedule I to Schedule III under 21 U.S.C. § 811 has been under review since May 2024. If finalized, rescheduling would allow cannabis businesses to deduct ordinary business expenses under 26 U.S.C. § 280E, potentially improving profitability by 15-30% for operators currently paying effective tax rates of 40-70%. However, the rulemaking process has been delayed multiple times, and a final rule is not expected before Q4 2026 at the earliest. Some industry observers project the decision could be delayed into 2027 depending on the outcome of ongoing litigation and the political environment. Congressional action on banking access remains uncertain. The SAFER Banking Act passed the Senate Banking Committee in September 2023 but has not received a floor vote. The bill would prohibit federal banking regulators from penalizing financial institutions for serving state-legal cannabis businesses, potentially opening access to traditional banking services for thousands of operators currently forced to operate on a cash basis. However, the legislation faces opposition from some lawmakers who view it as incremental legalization without comprehensive reform. The bill's prospects depend on the composition of Congress following the 2026 midterm elections. State-level policy changes will continue to shape market conditions. California is considering additional tax reforms, including replacing the 15% excise tax with a lower ad valorem tax on wholesale transactions. Oklahoma is debating whether to implement license caps to prevent future oversupply. Colorado's legislature is considering a bill to allow cannabis businesses to access state-law bankruptcy protections, though federal bankruptcy would remain unavailable. These state-level reforms could stabilize license counts in specific jurisdictions but are unlikely to reverse the national trend without federal action. New market openings will add licenses in specific states but are unlikely to offset national decline. Florida voters will decide on an adult-use legalization initiative in November 2026, which if approved could add 2,000-3,000 licenses by 2028. Pennsylvania, Ohio, and Minnesota are implementing adult-use programs that will add hundreds of licenses through 2027. However, these additions will be more than offset by continued attrition in oversupplied markets like Oklahoma, Oregon, and California. Industry analysts project the national license count will decline to 40,000-42,000 by Q4 2027 before stabilizing, representing a total reduction of 11-15% from the Q4 2023 peak. Stabilization will occur when supply and demand reach equilibrium, wholesale prices stop declining, and marginal operators achieve sustainable profitability or exit the market. The long-term industry structure will likely resemble the alcohol industry, with a small number of large operators controlling the majority of market share alongside a fragmented craft segment serving niche consumers. The top 20 MSOs are projected to control 60-70% of total sales by 2030, with thousands of small operators serving local markets and specialty segments. This structure will depend partly on whether states implement policies to protect small business participation, such as license caps, residency requirements, and restrictions on vertical integration. Social equity programs face an uncertain future as closure rates among equity licensees exceed the broader market. Illinois, Massachusetts, Michigan, and California are all reviewing their equity programs and considering reforms including emergency grants, technical assistance, and preferential licensing. However, without addressing the fundamental capital access barriers facing equity licensees, these programs are unlikely to achieve their stated goals of promoting participation by communities disproportionately harmed by prohibition.

Further Reading

• Marijuana Business Daily - Cannabis business license decline stretches past two-year mark (May 12, 2026): https://mjbizdaily.com/news/cannabis-business-license-decline-stretches-past-two-year-mark/615939/
• Whitney Economics - National Cannabis Market Reports and Analysis: https://whitneyeconomics.com/
• U.S. Drug Enforcement Administration - Notice of Proposed Rulemaking on Cannabis Rescheduling (May 2024): https://www.federalregister.gov/
• California Department of Cannabis Control - License Search and Statistics: https://cannabis.ca.gov/
• Oklahoma Medical Marijuana Authority - License Statistics and Reports: https://omma.ok.gov/
• Colorado Marijuana Enforcement Division - Market Data and Reports: https://sbg.colorado.gov/med
• National Cannabis Industry Association - Policy Positions and Advocacy: https://thecannabisindustry.org/
• Controlled Substances Act, 21 U.S.C. § 801 et seq.: https://www.govinfo.gov/content/pkg/USCODE-2021-title21/pdf/USCODE-2021-title21-chap13.pdf
• Internal Revenue Code Section 280E, 26 U.S.C. § 280E: https://www.law.cornell.edu/uscode/text/26/280E
• FinCEN Guidance on Marijuana-Related Businesses (February 2014): https://www.fincen.gov/resources/statutes-regulations/guidance/bsa-expectations-regarding-marijuana-related-businesses
• Leafly Jobs Report 2026: https://www.leafly.com/news/industry/cannabis-jobs-report
• New Frontier Data - U.S. Cannabis Market Reports: https://newfrontierdata.com/
• NORML - State-by-State Cannabis Laws: https://norml.org/laws/
• Marijuana Policy Project - State Policy Updates: https://www.mpp.org/states/

Update — May 12, 2026: Seven Consecutive Quarters of License Decline

The total number of active cannabis business licenses in the United States declined for the seventh consecutive quarter as of Q1 2026, according to MJBizDaily tracking data. The current license count sits 9% below the level recorded two years prior, marking the longest sustained contraction since state-legal markets began operating. The two-year decline reflects continued operator exits driven by oversupply, tax burdens, and tightening capital access.

The quarterly data shows no stabilization in license attrition across cultivation, retail, and manufacturing categories. Cultivation licenses bore the largest share of closures, with small-scale growers unable to compete against vertically integrated operators and falling wholesale flower prices. Retail closures accelerated in mature markets including Colorado, Oregon, and Washington, where store density exceeded sustainable levels and profit margins compressed below operational viability thresholds.

The sustained contraction matters operationally because fewer active licenses concentrate market share among larger, well-capitalized operators while eliminating small businesses and social equity participants. Access to capital remained the primary barrier to survival, with traditional lenders still prohibited from serving cannabis businesses under federal prohibition and private equity investors withdrawing from the sector. State regulators face pressure to adjust license caps, reduce renewal fees, and implement tax relief measures to prevent further market consolidation.

The seven-quarter decline also signals that earlier predictions of market stabilization were premature. Industry analysts now project license counts will continue falling through 2026 until federal rescheduling or banking reform provides relief. The contraction disproportionately affects social equity licensees, who entered markets later with less capital and now face the steepest competitive disadvantages, undermining state programs designed to promote diversity in cannabis ownership.